Peter Behner serves as Executive at MiNK Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter Behner has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 1, 2025 involved receiving (via award) 1,466 shares valued at $16.3K.
Peter Behner currently holds 20,115 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Behner has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
Peter Behner's most recent insider trade was on Dec 1, 2025, when they sold 1,466 shares at $11.09 per share.
Get notified when new Form 4 filings are submitted
| $13.86 |
| Discretionary |
| Sep 3, 2024 | INKT | $15.4K | Award | 18,753 | $0.82 | Discretionary |
| Jun 3, 2024 | INKT | $15.3K | Award | 15,454 | $0.99 | Discretionary |
| Mar 1, 2024 | INKT | $15.4K | Award | 16,185 | $0.95 | Discretionary |
| Dec 1, 2023 | INKT | $15.4K | Award | 14,784 | $1.04 | Discretionary |
| Sep 1, 2023 | INKT | $15.4K | Award | 10,531 | $1.46 | Discretionary |
| Jun 1, 2023 | INKT | $15.4K | Award | 8,736 | $1.76 | Discretionary |
| Mar 1, 2023 | INKT | $15.4K | Award | 7,357 | $2.09 | Discretionary |
| Dec 1, 2022 | INKT | $15.4K | Award | 5,891 | $2.61 | Discretionary |
| Sep 15, 2022 | INKT | $30.8K | Award | 11,737 | $2.62 | Discretionary |